000277433 001__ 277433
000277433 005__ 20240229155016.0
000277433 0247_ $$2doi$$a10.1097/JS9.0000000000000580
000277433 0247_ $$2pmid$$apmid:37418560
000277433 0247_ $$2ISSN$$a1743-9191
000277433 0247_ $$2ISSN$$a1741-6280
000277433 0247_ $$2ISSN$$a1741-6299
000277433 0247_ $$2ISSN$$a1743-9159
000277433 0247_ $$2altmetric$$aaltmetric:156423083
000277433 037__ $$aDKFZ-2023-01370
000277433 041__ $$aEnglish
000277433 082__ $$a610
000277433 1001_ $$0P:(DE-He78)6054b80d31ee94674ff76825fac01e0d$$aMaier, Christopher$$b0$$eFirst author$$udkfz
000277433 245__ $$aWeekday-dependent long-term outcomes in gastrointestinal cancer surgery: a german population-based retrospective cohort study.
000277433 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2023
000277433 3367_ $$2DRIVER$$aarticle
000277433 3367_ $$2DataCite$$aOutput Types/Journal article
000277433 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1698070504_11319
000277433 3367_ $$2BibTeX$$aARTICLE
000277433 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000277433 3367_ $$00$$2EndNote$$aJournal Article
000277433 500__ $$a#EA:A430#LA:A430# / 2023 Oct 1;109(10):3126-3136
000277433 520__ $$aFor most solid cancers, surgery represents the mainstay of curative treatment. Several studies investigating the effects of the weekday of surgery (WOS) on patient outcomes have yielded conflicting results. Barmer, the second-largest health insurance company in Germany, serves roughly 10% of the German population. We have used the Barmer database to evaluate how the weekday on which the surgery is performed influences long-term oncologic outcomes.For this retrospective cohort study, the Barmer database was used to investigate the effect of the WOS (Monday-Friday) on outcomes following oncological resections of the colorectum (n=49,003), liver (n=1,302), stomach (n=5027), esophagus (n=1126), and pancreas (n=6,097). In total, 62,555 cases from 2008 to 2018 were included in the analysis. The endpoints were overall survival (OS), postoperative complications, and necessity for therapeutic interventions or re-operations. We furthermore examined whether the annual caseload or certification as a cancer center influenced the weekday effect.We observed a significantly impaired OS for patients receiving gastric or colorectal resections on a Monday. Colorectal surgery performed on Mondays was associated with more postoperative complications and higher probability of re-operations. The annual caseload or a certification as a colorectal cancer center had no bearing on the observed weekday effect. There is evidence that hospitals schedule older patients with more comorbidities earlier in the week, possibly explaining these findings.This is the first study investigating the influence of the WOS on long-term survival in Germany. Our findings indicate that, in the German healthcare system, patients undergoing colorectal cancer surgery on Mondays have more postoperative complications and, therefore, require significantly more re-operations, ultimately lowering OS. This surprising finding appears to reflect an attempt to schedule patients with higher postoperative risk earlier in the week as well as semi-elective patients admitted on weekends scheduled for surgery on the next Monday.
000277433 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000277433 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000277433 7001_ $$aSchölch, Caroline$$b1
000277433 7001_ $$0P:(DE-He78)0116f5652cc0dbf455e3aa3914740230$$aZhu, Lei$$b2$$udkfz
000277433 7001_ $$aNzomo, Martial Mboulla$$b3
000277433 7001_ $$aL'hoest, Helmut$$b4
000277433 7001_ $$aMarschall, Ursula$$b5
000277433 7001_ $$aReißfelder, Christoph$$b6
000277433 7001_ $$0P:(DE-He78)a9d57fe3333789705a9ceb9ca904e83e$$aSchölch, Sebastian$$b7$$eLast author$$udkfz
000277433 773__ $$0PERI:(DE-600)2201966-2$$a10.1097/JS9.0000000000000580$$n10$$p3126-3136$$tInternational journal of surgery$$v109$$x1743-9191$$y2023
000277433 909CO $$ooai:inrepo02.dkfz.de:277433$$pVDB
000277433 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6054b80d31ee94674ff76825fac01e0d$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000277433 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0116f5652cc0dbf455e3aa3914740230$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000277433 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a9d57fe3333789705a9ceb9ca904e83e$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000277433 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000277433 9141_ $$y2023
000277433 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-08
000277433 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-08
000277433 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J SURG : 2022$$d2023-08-19
000277433 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-19
000277433 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-19
000277433 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-19
000277433 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-19
000277433 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bINT J SURG : 2022$$d2023-08-19
000277433 9202_ $$0I:(DE-He78)A430-20160331$$kA430$$lNWG-KKE Translationale Chirurgische Onkologie$$x0
000277433 9201_ $$0I:(DE-He78)A430-20160331$$kA430$$lNWG-KKE Translationale Chirurgische Onkologie$$x0
000277433 9200_ $$0I:(DE-He78)A430-20160331$$kA430$$lNWG-KKE Translationale Chirurgische Onkologie$$x0
000277433 980__ $$ajournal
000277433 980__ $$aVDB
000277433 980__ $$aI:(DE-He78)A430-20160331
000277433 980__ $$aUNRESTRICTED